Hit enter to search or ESC to close
Inceptua GroupInceptua GroupInceptua GroupInceptua Group
  • About
    • History
    • Mission
    • Quality
    • Leadership
    • Careers
  • Comparator Sourcing &
    Clinical Trial Services
  • Pre-approval &
    Unlicensed Medicines Access
    • For companies seeking support for access to their medicines
    • For physicians seeking access to unlicensed medicines
  • Inceptua
    Pharma
    • Jetrea®(ocriplasmin)
    • Farydak®(panobinostat)
  • News
    • Insights
    • News and Press Releases
  • Contact
    • General contacts
    • Partnering request
    • Medicines access requests
    • Safety and product complaints
    • Inceptua Pharma Access to Medicines Policy
  • IMAP Medicines Access Portal
  • 日本語
    Category

    Inceptua Pharma

    FeaturedInceptua PharmaPress release

    Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea® (Paclitaxel Micellar) in Europe   

    Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea® (Paclitaxel Micellar) in Europe       December 28 2020, Elevar Therapeutics, Inc, a fully integrated biopharmaceutical company built…
    Inceptua Group
    Inceptua GroupDecember 28, 2020
    FeaturedInceptua PharmaUpdate

    Helping get orphan drugs to patients quicker

    Across Europe there is disparity in the average time for new drugs to be approved and accessible to patients. There are a number of factors delaying these processes. Stuart Bell,…
    Stuart Bell
    Stuart BellOctober 7, 2020
    FeaturedInceptua PharmaUpdate

    Commercialize and partner successfully in Europe and the Middle East

    Dr. Stefan Fraenkel, Executive Vice President, Inceptua Pharma Understand how to commercialize via partnering in Europe and other markets outside of the USA. Dr. Stefan Fraenkel, Executive Vice President, Commercial…
    Stefan Fraenkel
    Stefan FraenkelNovember 1, 2018

    © 2021 Inceptua Group.
    Contact | Privacy policy | Terms of use | Cookie policy
    Anti-slavery and Human trafficking statement | Company information

    • About
      • History
      • Mission
      • Quality
      • Leadership
      • Careers
    • Comparator Sourcing &
      Clinical Trial Services
    • Pre-approval &
      Unlicensed Medicines Access
      • For companies seeking support for access to their medicines
      • For physicians seeking access to unlicensed medicines
    • Inceptua
      Pharma
      • Jetrea®(ocriplasmin)
      • Farydak®(panobinostat)
    • News
      • Insights
      • News and Press Releases
    • Contact
      • General contacts
      • Partnering request
      • Medicines access requests
      • Safety and product complaints
      • Inceptua Pharma Access to Medicines Policy
    • IMAP Medicines Access Portal
    • 日本語